CVS Health is set to close certain pharmacies within Target stores in the U.S. starting in February and concluding by the end of April, according to a company spokesperson. The move is part of CVS’s broader strategy to reduce its retail footprint, driven by evaluations of changes in population, consumer buying patterns, and anticipated future… Continue reading CVS to close ‘select’ pharmacies in Target stores in the coming months

Amazon is extending its cashierless checkout technology, known as the “Just Walk Out” system, to healthcare facilities. The latest version of the system allows healthcare employees to pay for items at on-site cafes using their work badge, providing a seamless and efficient checkout process. Additionally, hospital visitors will have the option to shop at Just… Continue reading Amazon’s cashierless checkout is coming to hospitals

YouTube has launched a feature named “First Aid Information Shelves” to combat medical misinformation, particularly during emergencies. The feature includes step-by-step videos from accredited health organizations, such as Mass General Brigham, on topics like CPR, seizures, choking, bleeding, and psychosis. These videos will appear at the top of relevant search results in the U.S., providing… Continue reading YouTube taps hospitals to create videos to help people witnessing an overdose or heart attack

The article discusses the financial burden of the “tampon tax” in the U.S., where some states impose sales tax on menstrual products, considering them “luxury items.” Over a lifetime, period products cost around $6,000 per person before tax. Currently, 21 states apply a sales tax of 4% to 7% on items like pads and tampons.… Continue reading States have been eliminating taxes on period products for years. Here’s where you’ll still pay them.

Moderna reported a significant decline in Covid vaccine sales for 2023, with revenue plunging by about two-thirds to $6.7 billion. This marked a stark contrast from the more than $18 billion in sales booked in 2022. The drop reflects waning demand for Covid products as cases subsided and public concern diminished. Despite the substantial decline,… Continue reading Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company’s $6 billion forecast

Johnson & Johnson has announced its plan to acquire Ambrx Biopharma for $2 billion in cash, a move aimed at bolstering its presence in the field of cancer treatment. Ambrx specializes in developing antibody-drug conjugates (ADCs), described as “guided missiles” that target and eliminate cancer cells while minimizing damage to healthy tissue. This strategic acquisition… Continue reading J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

The U.S. Food and Drug Administration (FDA) has granted approval to Florida’s groundbreaking plan to import cheaper prescription drugs from Canada, marking a historic move with potential implications for reducing drug costs in the United States. The decision is part of a broader, long-term effort to address the significant price disparity between medications in the… Continue reading Florida wins first FDA approval to import cheaper drugs from Canada

Eli Lilly is making waves in the pharmaceutical industry with the introduction of a groundbreaking website, LillyDirect, offering telehealth prescriptions and direct home delivery of certain drugs, including the popular weight loss treatment Zepbound. This move, a first-of-its-kind for a major drugmaker, aims to enhance patient access and address issues such as supply constraints and… Continue reading Eli Lilly’s direct drug sales alone may not upend the industry, but others could follow suit

Eli Lilly has introduced a new platform, LillyDirect, enabling patients to obtain prescriptions for weight loss drugs, including its recently approved Zepbound, through telehealth services. This initiative, a first of its kind by a pharmaceutical company, aims to enhance access to these medications, streamlining the prescription and delivery process. The move comes after the FDA… Continue reading Eli Lilly launches website to help patients get weight loss drugs

Walgreens witnessed a significant drop in its stock value, with shares falling over 11% following its fiscal first-quarter report. While the company’s adjusted earnings and revenue exceeded expectations, it announced a nearly 50% reduction in its quarterly dividend, cutting it from 48 cents to 25 cents per share to enhance its long-term balance sheet and… Continue reading Walgreens stock plunges after drugstore chain slashes quarterly dividend nearly in half

Moderna’s stock experienced a notable surge of over 15% after an upgrade by Oppenheimer, which shifted its rating to “outperform.” Despite a challenging 2023, marked by a nearly 45% decline in Moderna’s shares due to waning demand for its Covid vaccine, the upgrade was prompted by optimistic projections. The analysis anticipates that Moderna could introduce… Continue reading Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

In 2024, the United States will witness the inaugural negotiations between Medicare and drug manufacturers, determining the extent to which drug prices can be negotiated down, thereby establishing a precedent for a controversial process that may significantly impact what seniors pay for numerous medications by the end of the decade. President Joe Biden’s Inflation Reduction… Continue reading Biden administration’s Medicare drug price negotiations will face major tests in 2024